PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option? [0.03%]
克隆型22C3的PD-L1检测试剂盒在非小细胞肺癌患者中选择接受免疫检查点抑制剂治疗患者的可行性：细胞学细胞积是否可行？
Vanda F Torous,Deepa Rangachari,Benjamin P Gallant et al.
Vanda F Torous et al.
Introduction: Programmed death ligand 1 (PD-L1) testing of non-small cell lung cancer (NSCLC) specimens helps select patients most likely to respond to immune checkpoint inhibitors. PD-L1 immunohistochemical testing is ap...
Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinoma [0.03%]
转移性乳腺癌雌激素受体、孕酮受体和HER2状态的细胞学评估
Fresia Pareja,Melissa P Murray,Ryan Des Jean et al.
Fresia Pareja et al.
Background: Discordance in the receptor status between primary breast carcinomas (PBC) and corresponding metastasis is well documented. Interrogation of the receptor status of metastatic breast carcinoma (MBC) in cytology...
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations [0.03%]
P40和P63在肺癌细针抽吸细胞标本中的表达：理解临床误区及局限性
Mohammed T Lilo,Derek Allison,Yuting Wang et al.
Mohammed T Lilo et al.
Background: Fine-needle aspiration (FNA) biopsy of lung lesions is a highly accurate method for diagnosing and staging of lung cancers, particularly in patients with advanced cancer. Although, the majority of FNA cases of...
The head and neck region encompasses a variety of complex, intricate structures that can give rise to a plethora of epithelial tumors. As novel diagnostic entities and ancillary tests emerge in surgical pathology, translating this expanding...